Ophthalmology Times
A new topical ophthalmic antibacterial, besifloxacin ophthalmic suspension 0.6% (Besivance, Bausch & Lomb), administered via sterile ophthalmic drops, treats a broad range of eye pathogens including those that most commonly cause bacterial conjunctivitis.